Neo-Precision Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • IPO

  • Investors
  • 1

Neo-Precision Therapeutics General Information

Description

NPT Co Ltd is engaged in the Clinical development of new drugs and treatments for personalized medicine.

Contact Information

Website
www.neopt.jp
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Room 9, 16th floor, TOC Ariake East Tower
  • 3-5-7 Ariake, Koto-ku
  • Tokyo, 135-0063
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Room 9, 16th floor, TOC Ariake East Tower
  • 3-5-7 Ariake, Koto-ku
  • Tokyo, 135-0063
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neo-Precision Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. IPO 30-Jan-2025 Completed Generating Revenue
2. Later Stage VC 01-Jan-2024 Completed Generating Revenue
1. Later Stage VC (Series A) 27-Aug-2023 Completed Generating Revenue
To view Neo-Precision Therapeutics’s complete valuation and funding history, request access »

Neo-Precision Therapeutics Patents

Neo-Precision Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024237261-A1 Eukaryotic cell, method for producing eukaryotic cell, and pharmaceutical composition Inactive 14-May-2023
US-20250223322-A1 Parasporin expression vector and pharmaceutical composition Pending 15-Jul-2022
WO-2024014560-A1 Parasporin expression vector and pharmaceutical composition Inactive 15-Jul-2022
JP-7708411-B2 Method for preparing dendritic cells by cluster-controlled culture Active 09-Dec-2020

Neo-Precision Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neo-Precision Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nippon Shinyaku Corporation Minority
To view Neo-Precision Therapeutics’s complete investors history, request access »

Neo-Precision Therapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view Neo-Precision Therapeutics’s complete esg history, request access »

Neo-Precision Therapeutics FAQs

  • When was Neo-Precision Therapeutics founded?

    Neo-Precision Therapeutics was founded in 2018.

  • Where is Neo-Precision Therapeutics headquartered?

    Neo-Precision Therapeutics is headquartered in Tokyo, Japan.

  • What is the size of Neo-Precision Therapeutics?

    Neo-Precision Therapeutics has 7 total employees.

  • What industry is Neo-Precision Therapeutics in?

    Neo-Precision Therapeutics’s primary industry is Drug Discovery.

  • Is Neo-Precision Therapeutics a private or public company?

    Neo-Precision Therapeutics is a Private company.

  • What is Neo-Precision Therapeutics’s current revenue?

    The current revenue for Neo-Precision Therapeutics is .

  • Who are Neo-Precision Therapeutics’s investors?

    Nippon Shinyaku has invested in Neo-Precision Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process